Roche to acquire Arius

Roche (SWX:ROG) will acquire Arius (TSX:ARI) for about C$191 million (US$190.7 million) in cash. The pharma company will pay C$2.44 per Arius share, which is a 15% premium to Arius' close of C$2.13 on Tuesday, and acquire all of Arius' outstanding warrants. The deal gives Roche Arius' FunctionFirst antibody technology, which the pharma company initially plans to use in cancer and inflammatory diseases. ...